Objective: Once critically ill, preterm infants have transitioned to enteral or oral feedings, it is common to mix oral medications with milk feedings. The osmolality of oral and intravenous drugs were tested in the 1980s and many were found to exceed the American Academy of Pediatrics (AAP) recommended limit (400 mOsm kg À1 H 2 O). Many new milks and medications have entered the neonatal intensive care unit (NICU) since then. The objective of this study was to measure the osmolality of common milk-medication combinations administered in the NICU.
Introduction
One of the markers of recovery for the preterm infant is the transition to naso-gastric, and then oral feedings and medications from total parenteral nutrition and intravenous fluids. For the complex infant receiving multiple medications and working up to full enteral feedings, these substances are often mixed with milk feedings for q6, 8 or 12 h dosing. Preterm infants are prone to frequent interruptions in their feeding schedules due to 'intolerance' for a variety of reasons, among which the 'new milk cocktail' should not be overlooked. Available oral medications often have osmolalities in excess of the recommended limit of 400 mOsm kg À1 H 2 O set out by the American Academy of Pediatrics. 1 This information may not always be readily available for each drug. It is thought that dilution of these substances in milk mixtures will reduce the osmolar challenge.
Ernst et al. 2 tested the osmolality of oral and intravenous drugs in the 1980s and found many to exceed the Academy of Pediatrics (AAP) recommended limit. In the intervening 25 to 30 years, new milks and medications have entered the neonatal intensive care unit (NICU) and merit a contemporary review.
The purpose of this study was to measure the osmolality of common milk-medication combinations administered in the NICU today.
Methods
Single bottles of 20, 22, 24 and 30 kcal per oz commercial formula used in the NICU were obtained (see Table 1 ). EleCare (Ross Products Division, Abbott Nutrition, Columbus, OH, USA) was prepared from powder according to the manufacturer's instructions for both 20 and 30 kcal per oz milks. Several waste samples of human milk were obtained after the day's preparation and pooled as a representative specimen. In addition to plain human milk, milk fortified to 24 kcal per oz with formula (Similac Special Care 30, Ross Products, Abbott Nutrition, Columbus, OH, USA) was tested. A 20 ml volume of human milk or formula was chosen as a reasonable simulation of a single feeding for a 1 kg infant at full volume feeds (160 ml kg À1 per day). That volume was further reduced to the working test volume (5 ml).
Medications commonly used in the ELBW patient were obtained from the hospital pharmacy or purchased over the counter (Table 2) . Dosing was according to NeoFax (Thomson Reuters, New York, NY, USA) and reduced to 1 4 volume to proportionally match the feeding volume. Oral electrolytes were tested at 3 mEq per 100 ml sodium and 2 mEq per 100 ml potassium as sodium and potassium chloride, respectively. Drug alone was analyzed for osmolality before addition to milk. The maintenance dose of caffeine was chosen rather than the loading dose. Aldactone and chlorothiazide were tested together as they are most often administered that way.
Osmolality was obtained by freezing point depression using the Model 3320 Osmometer (Advanced Instruments, Norwood, MA, USA). Calibration standards (50, 850 and 2000 mOsm kg À1 H 2 O) were obtained from the manufacturer and run monthly. A reference solution (290 mOsm kg À1 H 2 O) was run daily before each study run. Samples were analyzed in triplicate (20 ml each). The testing cycle is described in Figure 1 .
Results
All unadulterated milks tested were well within the limits set by the AAP, with the exception of EleCare 30 that had an osmolality of 565 mOsm kg À1 H 2 O. A number of single medications were found to have very high osmolalities ( Table 2 ). The addition of liquid vitamins alone increased milk osmolalities above the AAP limit (Figure 2 ). Sequential testing of milk with chronic diuretics, supplemental electrolytes and caffeine, a common mixture for infants with chronic lung disease, produced the profiles shown in Figure 3 . Due to its very high osmolality (described as 2000 mOsm kg À1 H 2 O in NeoFax), phenobarbital was tested as a single drug additive in each milk and resulted in osmolalities from 644 to 776 mOsm kg À1 H 2 O (data not shown). Milks with all additives resulted in osmolalities between 1500 and 2000 mOsm kg À1 H 2 O (data not shown).
Discussion
Commonly prescribed medications for the preterm infant are switched from intravenous to oral preparations as infants exhibit a tolerance for enteral feedings. Many infants, owing to complications of prematurity or chronic clinical conditions, may require more than one medication daily, such as diuretics, electrolyte supplements, anticonvulsants, and so on. Before discharge, almost all infants are prescribed vitamin or iron supplements as well. Milk feedings (formula and human milk) are regularly used as a vehicle for administering these medications, as dosing times often coincide with feeding times, and there is a presumption that mixing the medication makes the drug more tolerable for the infant. However, there have been numerous reports of feeding intolerance or necrotizing enterocolitis associated with hyperosmolar feedings. [3] [4] [5] [6] [7] [8] In 1978, Pascale et al. 9 showed that a high osmolar load delayed gastric emptying in low birth weight infants. In our study, the addition of vitamin drops, alone, sent all milks tested well over the AAP recommended osmolality limit of For infants receiving these mixtures, the risk for gastrointestinal compromise should be kept in mind, especially if an infant begins to show increased gastric residuals or spitting. It is possible that an infant's own gastric fluids may also exert an influence on osmolality, but this is not currently known and merits additional study.
Infants that have experienced severe gastrointestinal complications (one or more episodes of necrotizing enterocolitis, short bowel syndrome, severe gastroesophageal reflux, and so on). may require the use of hydrolyzed milk products or elemental formulas for enteral nutrition. Additives to these formulas must be used cautiously owing to the effects each may have on the osmotic load. Healthcare professionals should consider options for dosing schedules, perhaps encouraging single medication administrations, so as few drugs as possible can be given in combination with feedings.
